Interviewtimes 
The first clinical trial report of India’s own coronavirus vaccine Covaxin has been released. The report has reassured the public, including vaccine maker Bharat Biotech. According to the company, the first clinical trial showed that the vaccine developed antibodies in the body, but did not show any side effects.
“Any side effects that have been shown to the people have also been cured very quickly without any medication,” company officials said. Similarly, the pain caused by vaccination in the body has also been automatically cured. Now Covaxin, along with two other vaccines, has appealed to the government for emergency use.
A few days ago, Suchitra Ella, Joint Director, Bharat Biotech, India, hoped that Covaxin would be available in the country in the first three months of 2021 with safety and power. She also hoped that the government’s vaccination program in the country would provide first-class Covaxin.
